Management of Generalized Anxiety and Related Disorders
Hours: 1.25
Knowledge, expertise, and familiarity with the various drugs used to treat anxiety disorders are fundamental for proper treatment and patient safety. It is necessary that pharmacists properly monitor for commonly serious adverse effects of medications. They can also play a vital role in education and help provide counseling tips and recommendations for selecting an optimal medication based on patient-specific factors.
Knowledge, expertise, and familiarity with the various drugs used to treat anxiety disorders are fundamental for proper treatment and patient safety. It is necessary that pharmacists properly monitor for commonly serious adverse effects of medications. They can also play a vital role in education and help provide counseling tips and recommendations for selecting an optimal medication based on patient-specific factors.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.25 Nursing Contact Hours after successfully completing this course.
Accreditation Council for Continuing Medical Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Relias LLC designates this enduring activity for a maximum of 1.25 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.2000 contact hours for participating in this course.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.0000 contact hours for participating in this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.25 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Florida Board of Medicine
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.25 AMA PRA category 1 Credits™.
Ohio State Medical Board
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Physicians will receive 1.25 AMA PRA category 1 Credits™.
Louisiana State Board of Medical Examiners
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 1.25 AMA PRA category 1 Credits™.
Mississippi State Board of Medical Licensure
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 1.25 AMA PRA category 1 Credits™.
New Mexico Medical Board
Physicians will receive 1.25 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board Of Medical Examiners
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)
Physicians will receive 1.25 AMA PRA category 1 Credits™
Florida Physician Assistants
Florida Physician Assistants (CEBroker Provider #50-290)
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: Knowledge
Target Audience Designation: P
ACPE Universal Activity Number: JA4008266-0000-22-010-H01-P
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 1.25 contact hours.
Identify the various types of anxiety disorders and their common characteristics
Recognize various drug classes and pharmacotherapy options for treating anxiety disorders regarding their safety, efficacy, and place in therapy.
Define the pharmacist’s role in the management of anxiety disorders.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Overview
Epidemiology
Overview of Treatment Principles
Anxiety Due to a Physical Condition or Substance Use
Acute Anxiety
Types of Anxiety Disorders
Diet and General Counseling Points
Section 3: Pharmacological Therapy
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Miscellaneous Agents
Tricyclic Antidepressants
Section 4: Further Pharmacological Therapy
Benzodiazepines
Antiseizure Medications
Antihypertensive Medications
Atypical Antidepressants
Antihistamines
Monoamine Oxidase Inhibitors (MAOIs)
Atypical Antipsychotics
Black Box Warning
Jitteriness Syndrome
Section 5: Clinical Vignette
Meet Amber
Section 6: Conclusion
Course Summary
Course Contributors
References
Sean Kennard is an Air Force veteran with 10 years of active-duty service plus clinical experience in various mental health settings. Sean was educated and trained In Virginia as a Registered Nurse, where he practiced pediatric behavioral health nursing at Cumberland Hospital for Children and Adolescents in New Kent. He earned his Associate’s Degree in Nursing from ECPI University and Bachelor of Science in Nursing from Western Governors University. Sean is a former Program Director of a Senior Behavioral Health Unit and currently coaches licensure exam strategies to nursing graduates. His clinical skillset is in behavioral health across the lifespan, including behavioral case management and geropsychiatric nursing. He most recently worked as a Forensic Psych Nurse at Central State Hospital in Georgia during the onset of the pandemic before contracting with Relias as a Behavioral Health Subject Matter Expert Technical Writer.Writer: Kimberly Workman, MA
Ms. Workman is an Instructional Designer at Relias. She has a Master of Arts in Technology and Communication, as well as graduate certificates in Public Health, Epidemiology, and Digital Communications. Ms. Workman has a background in writing and designing online continuing medical education for physicians and other health professionals on multiple educational platforms, including web-based, game-based, and immersive learning environments. She has also used simulation training extensively to connect learning to real-world environments.
The target audience for this course is: Intermediate level Social Workers; Nurses; Pharmacists; Physicians; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
